Jefferies Defending Foghorn Therapeutics (FHTX) +10pct Drop: 'We view the recent pullback as a buying opportunity'

March 12, 2026 4:44 PM

Jefferies analyst Amin Makarem reiterated a Buy rating and $12.00 price target on Foghorn Therapeutics (NASDAQ: FHTX).The analyst comments "FHTX ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found